Validation of the Patient-Rated Version of the Parkinson Anxiety Scale in Iranian People with Parkinson’s Disease
Validation of the Patient-Rated Version of the Parkinson Anxiety Scale in Iranian People with Parkinson’s Disease
Where did the research take place?
The study site has not been established. Author addresses may differ from where the research occurred.
A plain-language reading has not been prepared for this paper yet.
Original abstract
To evaluate the psychometric properties of the Patient-Rated Parkinson's Anxiety Scale (PAS-PR) in people with Parkinson's Disease (PwPD).In this cross-sectional study, we assessed Persian-speaking PwPD using the PAS-PR. Psychometric evaluation included: exploratory factor analysis (EFA); internal consistency (Cronbach's α), test - retest reliability (Intraclass Correlation Coefficient); PAS-PR/observer-rated PAS (PAS-OR) agreement (Bland-Altman); and convergent validity against Geriatric Anxiety Inventory (GAI), the Hospital Anxiety and Depression Scale-Anxiety (HADS-A), the Beck Anxiety Inventory (BAI), and the 21-item Depression, Anxiety, and Stress Scale (DASS-21).Among 191 PwPD (58% male, mean age 69.2 ± 4.6 years; Hoehn & Yahr stages 1-4: 36.7%, 42.4%, 18.3%, and 2.6%, respectively), EFA revealed the expected three-factor structure. The PAS-PR demonstrated excellent reliability (α = 0.88; ICC = 0.96) and strong agreement with PAS-OR (96.19%). Convergent validity was established through significant correlations with GAI, HADS-A, BAI and DASS-21 (r = 0.61-0.75).The PAS-PR, with its acceptable psychometric properties, proves to be a valuable tool for assessing anxiety in the Persian-speaking PwPD.The PAS-PR offers a practical, tailored tool for identifying diverse anxiety symptoms in Parkinson's patients, streamlining screening in clinical settings.